Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera

Clinical and Vaccine Immunology

Volumn 18, Issue 5, 2011, Pages 844-850

  Alam, Mohammad Murshid ^a   Riyadh, M Asrafuzzaman ^a   Fatema, Kaniz ^a   Rahman, Mohammad Arif ^a   Akhtar, Nayeema ^a   Ahmed, Tanvir ^a   Chowdhury, Mohiul Islam ^a   Chowdhury, Fahima ^a   Calderwood, Stephen B ^b,c   Harris, Jason B ^b,c   Ryan, Edward T ^b,c,d   Qadri, Firdausi ^a  

^a ICDDRB Laboratory Sciences Division   (Bangladesh)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN B SUBUNIT; CHOLERA VACCINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INACTIVATED VACCINE; LIPOPOLYSACCHARIDE;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; BANGLADESH; CHOLERA; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; NATURALLY ACQUIRED CHOLERA; PRIORITY JOURNAL; REPEATED DRUG DOSE; SEROCONVERSION; SINGLE DRUG DOSE;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; ANTITOXINS; B-LYMPHOCYTES; BANGLADESH; BLOOD BACTERICIDAL ACTIVITY; CHOLERA; CHOLERA VACCINES; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; MALE; MIDDLE AGED; TIME FACTORS; VACCINATION; VACCINES, INACTIVATED; VIBRIO CHOLERAE; YOUNG ADULT;

EID: 79955733279     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00562-10     Document Type: Article

References (42)

1. Ahmed, T., A. M. Svennerholm, A. Al Tarique, G. N. Sultana, and F. Qadri. 2009. Enhanced immunogenicity of an oral inactivated cholera vaccine in infants in Bangladesh obtained by zinc supplementation and by temporary withholding breast-feeding. Vaccine 27:1433-1439.
2. Chowdhury, F., et al. 2008. A comparison of clinical and immunologic features in children and older patients hospitalized with severe cholera in Bangladesh. Pediatr. Infect. Dis. J. 27:986-992.
3. Clemens, J. D., et al. 1986. Field trial of oral cholera vaccines in Bangladesh. Lancet ii:124-127. (Pubitemid 16098257)
4. Clemens, J. D., et al. 1990. Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet 335:270-273. (Pubitemid 20047723)
5. Crotty, S., R. D. Aubert, J. Glidewell, and R. Ahmed. 2004. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J. Immunol. Methods 286:111-122.
6. Crotty, S., et al. 2003. Cutting edge: long-term B-cell memory in humans after smallpox vaccination. J. Immunol. 171:4969-4973. (Pubitemid 37432774)
7. Elson, C. O., and W. Ealding. 1984. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J. Immunol. 132:2736-2741. (Pubitemid 14105650)
8. Harris, A. M., et al. 2009. Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh. Infect. Immun. 77:3850-3856.
9. Harris, A. M., et al. 2008. Shifting prevalence of major diarrheal pathogens in patients seeking hospital care during floods in 1998, 2004, and 2007 in Dhaka, Bangladesh. Am. J. Trop. Med. Hyg. 79:708-714.
10. Harris, J. B., et al. 2010. Cholera's western front. Lancet 376:1961-1965.
11. Harris, J. B., et al. 2008. Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh. PLoS Negl. Trop. Dis. 2:e221.
12. Jayasekera, C. R., et al. 2008. Cholera toxin-specific memory B-cell responses are induced in patients with dehydrating diarrhea caused by Vibrio cholerae O1. J. Infect. Dis. 198:1055-1061.
13. Jertborn, M., A. M. Svennerholm, and J. Holmgren. 1988. Five-year immunologic memory in Swedish volunteers after oral cholera vaccination. J. Infect. Dis. 157:374-377.
14. Jertborn, M., A. M. Svennerholm, and J. Holmgren. 1994. Immunological memory after immunization with oral cholera B subunit-whole-cell vaccine in Swedish volunteers. Vaccine 12:1078-1082.
15. Kanungo, S., et al. 2009. Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial. Vaccine 27:6887-6893.
16. Kendall, E. A., et al. 2010. Development of immunoglobulin M memory to both a T-cell-independent and a T-cell-dependent antigen following infection with Vibrio cholerae O1 in Bangladesh. Infect. Immun. 78:253-259.
17. Koelle, K., X. Rodo, M. Pascual, M. Yunus, and G. Mostafa. 2005. Refractory periods and climate forcing in cholera dynamics. Nature 436:696-700. (Pubitemid 41117271)
18. Lee, J. B., J. E. Jang, M. K. Song, and J. Chang. 2009. Intranasal delivery of cholera toxin induces th17-dominated T-cell response to bystander antigens. PLoS One 4:e5190.
19. Legros, D., et al. 1999. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp. Bull. World Health Organ. 77:837-842.
20. Levine, M. M., et al. 1981. Duration of infection-derived immunity to cholera. J. Infect. Dis. 143:818-820.
21. Mahalanabis, D., et al. 2008. A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India. PLoS One 3:e2323.
22. Merrell, D. S., et al. 2002. Host-induced epidemic spread of the cholera bacterium. Nature 417:642-645. (Pubitemid 34614821)
23. Qadri, F., et al. 1999. Lipopolysaccharide- and cholera toxin-specific subclass distribution of B-cell responses in cholera. Clin. Diagn. Lab. Immunol. 6:812-818.
24. Qadri, F., et al. 1995. Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1. Clin. Diagn. Lab. Immunol. 2:685-688.
25. Qadri, F., et al. 1997. Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1. Infect. Immun. 65:3571-3576.
26. Ryan, E. T., and S. B. Calderwood. 2000. Cholera vaccines. Clin. Infect. Dis. 31:561-565.
27. Ryan, E. T., S. B. Calderwood, and F. Qadri. 2006. Live attenuated oral cholera vaccines. Expert Rev. Vaccines 5:483-494. (Pubitemid 44627880)
28. Saha, D., et al. 2004. Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh. J. Infect. Dis. 189:2318-2322.
29. Sanchez, J. L., et al. 1994. Protective efficacy of oral whole-cell/recombinant- B-subunit cholera vaccine in Peruvian military recruits. Lancet 344:1273-1276. (Pubitemid 24334686)
30. Schwartz, B. S., et al. 2006. Diarrheal epidemics in Dhaka, Bangladesh, during three consecutive floods: 1988, 1998, and 2004. Am. J. Trop. Med. Hyg. 74:1067-1073.
31. Shamsuzzaman, S., et al. 2009. Robust gut associated vaccine-specific antibody- secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent Vibrio cholerae O1/O139 whole-cell cholera vaccine: comparison with other mucosal and systemic responses. Vaccine 27:1386-1392.
32. Sur, D., et al. 2009. Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, doubleblind, placebo-controlled trial. Lancet 374:1694-1702.
33. Trach, D. D., et al. 2002. Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam. Bull. World Health Organ. 80:2-8.
34. Vajdy, M., and N. Lycke. 1993. Stimulation of antigen-specific T- and B-cell memory in local as well as systemic lymphoid tissues following oral immunization with cholera toxin adjuvant. Immunology 80:197-203. (Pubitemid 23308571)
35. Vajdy, M., and N. Y. Lycke. 1992. Cholera toxin adjuvant promotes longterm immunological memory in the gut mucosa to unrelated immunogens after oral immunization. Immunology 75:488-492.
36. Waldor, M. K., R. Colwell, and J. J. Mekalanos. 1994. The Vibrio cholerae O139 serogroup antigen includes an O-antigen capsule and lipopolysaccharide virulence determinants. Proc. Natl. Acad. Sci. U. S. A. 91:11388-11392.
37. Weil, A. A., et al. 2009. Memory T-cell responses to Vibrio cholerae O1 infection. Infect. Immun. 77:5090-5096.
38. Wenneras, C., F. Qadri, P. K. Bardhan, R. B. Sack, and A. M. Svennerholm. 1999. Intestinal immune responses in patients infected with enterotoxigenic Escherichia coli and in vaccinees. Infect. Immun. 67:6234-6241.
39. World Health Organization. 2010. Cholera in Pakistan: WHO global alert and response. World Health Organization, Geneva, Switzerland.
40. World Health Organization. 2010. Cholera vaccines: WHO position paper- recommendations. Vaccine 28:4687-4688.
41. World Health Organization. 2009. Cholera annual report 2008. Wkly. Epidemiol. Rec. 84:309-324.
42. Zuckerman, J. N., L. Rombo, and A. Fisch. 2007. The true burden and risk of cholera: implications for prevention and control. Lancet Infect. Dis. 7:521-530.